SALEM, Mass. — Commonwealth Diagnostics International (CDI) proudly announces a new in-network agreement with Premera Blue Cross, expanding access to our hydrogen and methane breath testing for over 2.8 million lives in Washington State and Alaska. This latest agreement underscores CDI’s commitment to enhancing the accessibility and affordability of breath testing for SIBO, IMO, and…
SALEM, Mass. — Commonwealth Diagnostics International (CDI) is excited to share the benefits of our new in-network status with CareFirst BlueCross BlueShield and CareFirst BlueChoice, the most extensive not-for-profit health plan in the Mid-Atlantic. This partnership, covering over 3.5 million individuals and groups in Maryland, the Washington D.C. metropolitan area, and parts of Virginia, significantly enhances…
SALEM, Mass. — Commonwealth Diagnostics International, Inc. (CDI), The Leader in Hydrogen and Methane Breath Testing®, is now in-network with Blue Cross and Blue Shield of Illinois (BCBSIL), the state’s largest health insurance company. This significant development is part of CDI’s ongoing efforts to enhance accessibility to its clinically validated non-invasive at-home breath tests for…
MyGI Gateway will transform hydrogen and methane breath testing with streamlined kit registration, advanced patient engagement, and analytics throughout the diagnostic process. SALEM, Mass. – October 20, 2023 – Commonwealth Diagnostics International, Inc. (CDI), The Leader In Hydrogen and Methane Breath Testing®, is excited to announce the launch of MyGI Gateway™, a cutting-edge cloud-based provider…
Collaboration will accelerate and streamline gastroenterology (GI) clinical trials with an end-to-end platform for patient recruitment, enrollment, and management Salem, Mass. and Fremont, Calif. – October 20, 2022 – My Total Health Inc., in partnership with Commonwealth Diagnostics International, Inc. (CDI), announced today a strategic partnership with CliniOps in which the companies will collaborate…
Commonwealth Diagnostics International, Inc. (CDI), an innovative GI health company providing industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments, today announced expanded access to the naturopathic and integrative medicine community through a strategic partnership with Rupa Health, a digital health platform making it…
Salem, Mass. – August 11, 2022 – Commonwealth Diagnostics International, Inc. (CDI), an innovative GI health company providing industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments, is proud to be recognized as one of the Top 100 Healthcare Technology Companies of 2022 by…
Collaboration will expand MyGiHealth’s Learning and Treatment Centers as well as provide greater access to providers across the full spectrum of gastroenterology Salem, Mass. (October 26, 2021) – My Total Health Inc., in strategic partnership with Commonwealth Diagnostics International, Inc. (CDI), announced it will expand education content available via its MyGiHealth application with a new…
Salem, Mass. – June 29, 2021 – Commonwealth Diagnostics International, Inc. (CDI) is pleased to announce that two of its cofounders, Craig Strasnick and Gray W. Rifkin, were honored recently amongst their peers in both business and healthcare. Strasnick, CDI President and CEO, was named to the Forbes Next 1000 list of upstart entrepreneurs redefining…
Salem, Mass. – May 21, 2021 – Over the past 10 years, Commonwealth Diagnostics International, Inc. (CDI) leadership team has worked closely with industry stakeholders to support the gastroenterology (GI) community. Today, CDI is pleased to announce it has expanded partnerships with several industry and research partners both in the United States and abroad, including…
